Contemporary Management of Stable Coronary Artery Disease

[1]  C. Berry,et al.  Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis , 2022, Journal of the American Heart Association.

[2]  A. Editorial.  Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. , 2022, Revista espanola de cardiologia.

[3]  M. Penicka,et al.  Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve , 2021, Frontiers in Cardiovascular Medicine.

[4]  A. Candreva,et al.  Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner. , 2021, Journal of the American College of Cardiology.

[5]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[6]  D. Perera,et al.  Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  A. Candreva,et al.  Simplified Assessment of the Index of Microvascular Resistance , 2021, Journal of interventional cardiology.

[8]  A. Candreva,et al.  Basics of Coronary Thermodilution. , 2021, JACC. Cardiovascular interventions.

[9]  ShengOlivia R. Liu,et al.  Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study , 2021, The Lancet.

[10]  R. Gibbons,et al.  Declining Accuracy of the Traditional Diamond-Forrester Estimates of Pretest Probability of Coronary Artery Disease: Time for New Methods. , 2021, JAMA internal medicine.

[11]  P. Houthuizen,et al.  High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study. , 2021, International journal of cardiology.

[12]  A. Candreva,et al.  Thermodilution-Derived Volumetric Resting Coronary Blood Flow Measurement in Humans. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  J. Bartunek,et al.  Duration of Hyperemia With Intracoronary Administration of Papaverine , 2021, Journal of the American Heart Association.

[14]  K. Fox.  Response by Fox to Letter Regarding Article, "The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease". , 2021, Circulation.

[15]  Jun-Jie Zhang,et al.  3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. , 2020, JACC. Cardiovascular interventions.

[16]  Steffen E. Petersen,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2016, European journal of preventive cardiology.

[17]  ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.

[18]  D. Andreini,et al.  Implementing Coronary Computed Tomography Angiography in the Catheterization Laboratory. , 2020, JACC. Cardiovascular imaging.

[19]  H. Bøtker,et al.  Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease. , 2020, European heart journal.

[20]  Ulf J Jensen,et al.  Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. , 2020, Journal of the American College of Cardiology.

[21]  Charles A. Taylor,et al.  Non‐invasive procedural planning using computed tomography‐derived fractional flow reserve , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  A. Baumbach,et al.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. , 2020, European heart journal.

[23]  D. Wood,et al.  Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction , 2020, Circulation. Cardiovascular interventions.

[24]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[25]  Deepak L. Bhatt,et al.  Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. , 2019, European heart journal.

[26]  C. V. van Mieghem,et al.  Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[27]  E. Barbato,et al.  Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis. , 2019, Journal of the American College of Cardiology.

[28]  Deepak L. Bhatt,et al.  Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. , 2019, Lancet.

[29]  M. Sabatine,et al.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. , 2019, European heart journal.

[30]  Eloisa Arbustini,et al.  Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. , 2019, European heart journal.

[31]  D. Glineur,et al.  Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. , 2019, European heart journal.

[32]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[33]  M. D. Di Carli,et al.  Estimating Pre-Test Probability of Coronary Artery Disease: Battle of the Scores in an Evolving CAD Landscape. , 2019, JACC. Cardiovascular imaging.

[34]  E. Prescott,et al.  Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. , 2018, European heart journal.

[35]  J. Andreasen,et al.  Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting. , 2018, Journal of the American College of Cardiology.

[36]  Odyssey Outcomes Investigators.  Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome , 2018 .

[37]  M. D. Di Carli,et al.  Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[38]  Thomas Kahan,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[39]  E. Barbato,et al.  Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery , 2018, Circulation. Cardiovascular interventions.

[40]  Jeroen J. Bax,et al.  The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability , 2018, European heart journal.

[41]  G. Condorelli,et al.  Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis , 2018, JAMA cardiology.

[42]  P. Jüni,et al.  Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). , 2017, Circulation.

[43]  Akiko Maehara,et al.  Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT Study. , 2017, JACC. Cardiovascular imaging.

[44]  Deepak L. Bhatt,et al.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[45]  J. Fujimoto,et al.  Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study. , 2017, Journal of the American College of Cardiology.

[46]  E. Omerovic,et al.  Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI , 2017, The New England journal of medicine.

[47]  A. Jeremias,et al.  Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI , 2017, The New England journal of medicine.

[48]  A. Keech,et al.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease , 2017, The New England journal of medicine.

[49]  W. Koenig,et al.  Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. , 2016, JAMA.

[50]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[51]  Habib Samady,et al.  Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial , 2016, The Lancet.

[52]  J. Ottervanger,et al.  Rationale and Design , 2022 .

[53]  L. Räber,et al.  Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment. , 2016, European heart journal.

[54]  J. Abdulla,et al.  Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis. , 2016, European heart journal cardiovascular Imaging.

[55]  P. Stella,et al.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. , 2015, European heart journal.

[56]  Francesco Versaci,et al.  Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study. , 2015, JACC. Cardiovascular imaging.

[57]  Akiko Maehara,et al.  Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention). , 2015, JACC. Cardiovascular interventions.

[58]  Matthias Gutberlet,et al.  Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study , 2015, European heart journal.

[59]  William Wijns,et al.  Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study , 2015, European heart journal.

[60]  Scot-Heart Investigators,et al.  CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial , 2015, The Lancet.

[61]  Marc P. Bonaca,et al.  Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[62]  E. Yow,et al.  A selection of recent, original research papers , 2015, Journal of Nuclear Cardiology.

[63]  Braunwald,et al.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.

[64]  D. Berman,et al.  Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. , 2014, JACC. Cardiovascular imaging.

[65]  B. Dimitrov,et al.  Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study , 2014, Circulation. Cardiovascular interventions.

[66]  Hiroshi Ito,et al.  Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). , 2014, Journal of the American College of Cardiology.

[67]  Evelyn Regar,et al.  In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. , 2014, European heart journal.

[68]  P. Serruys,et al.  Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[69]  T. Biering-Sørensen,et al.  Myocardial Strain Analysis by 2-Dimensional Speckle Tracking Echocardiography Improves Diagnostics of Coronary Artery Stenosis in Stable Angina Pectoris , 2013, Circulation. Cardiovascular imaging.

[70]  G. Mancia,et al.  Clinical Management of Coronary Heart Disease in Hypertension , 2013, High Blood Pressure & Cardiovascular Prevention.

[71]  Charles A. Taylor,et al.  Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: scientific basis. , 2013, Journal of the American College of Cardiology.

[72]  L. Wallentin,et al.  New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis , 2013, European heart journal.

[73]  E. Picano,et al.  Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. , 2012, JACC. Cardiovascular imaging.

[74]  Michail I. Papafaklis,et al.  Prediction of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Endothelial Shear Stress and Arterial Plaque Characteristics: The PREDICTION Study , 2012, Circulation.

[75]  C. Terkelsen,et al.  Global left ventricular longitudinal systolic strain for early risk assessment in patients with acute myocardial infarction treated with primary percutaneous intervention. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[76]  N. Bruining,et al.  Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures , 2012, European heart journal.

[77]  Erik Jørgensen,et al.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.

[78]  Paul Burton,et al.  Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[79]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[80]  I. Meredith,et al.  Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve. , 2012, European heart journal.

[81]  A. Arbab-Zadeh,et al.  Quantification of coronary arterial stenoses by multidetector CT angiography in comparison with conventional angiography methods, caveats, and implications. , 2011, JACC. Cardiovascular imaging.

[82]  F. Alfonso,et al.  Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. , 2010, Journal of the American College of Cardiology.

[83]  B. Gersh,et al.  Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .

[84]  Uwe Siebert,et al.  Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .

[85]  K. Oldroyd,et al.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. , 2010, Journal of the American College of Cardiology.

[86]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[87]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[88]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[89]  Jennifer G. Robinson,et al.  Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. , 2009, Journal of the American College of Cardiology.

[90]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[91]  M. Hunink,et al.  Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. , 2007, American heart journal.

[92]  O. Penn,et al.  Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. , 2007, The Annals of thoracic surgery.

[93]  Diederick E Grobbee,et al.  Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. , 2007, JAMA.

[94]  S. Nissen,et al.  The ASTEROID trial: coronary plaque regression with high-dose statin therapy. , 2006, Future cardiology.

[95]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[96]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[97]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[98]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[99]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[100]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.